[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fshhKAsY-ZP0RAtvQw2evEQovs7rm5fRjQg0DplMPmWU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":46,"rows":53},"University of Thessaly",[4],187,false,40,1,29668,3,170,[14,17,20,23,26,28,30,33],{"name":15,"count":16},"Body Composition",9,{"name":18,"count":19},"Oxidative Stress",8,{"name":21,"count":22},"Skeletal Muscle Damage",7,{"name":24,"count":25},"Energy Expenditure",6,{"name":27,"count":25},"Resting Metabolic Rate",{"name":29,"count":25},"Muscle Damage",{"name":31,"count":32},"Chronic Pain",5,{"name":34,"count":32},"Chronic Musculoskeletal Pain",[36,41],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT04947059","Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)","2025-10","Gemcitabine Hydrochloride combined with continuous saline irrigation",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT05565287","Neonatal Neurobehavioral And Motor Behavior In Ultra Early Physical Therapy Intervention","2025-10-30","ultra early physiotherapy intervention",[47,48,49,50,51,52],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[54,79,97,122,150,168,196,214,240,266,292,331,369,395,413,440,468,486,511,542,560],{"intervention":40,"totalTrials":9,"cells":55},{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":75,"NA":77},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":58},[],{"trials":64,"activeCount":9,"soonestReadout":39},[65],{"nctId":37,"briefTitle":38,"status":66,"phases":67,"primaryCompletion":39,"completion":68,"start":69,"enrollment":70,"conditions":71,"interventions":73},"RECRUITING",[50],"2026-10","2021-12-14",180,[72],"Bladder Cancer",[40,74],"Epirubicin Hydrochloride combined with continuous saline irrigation",{"trials":76,"activeCount":58},[],{"trials":78,"activeCount":58},[],{"intervention":74,"totalTrials":9,"cells":80},{"EARLY_PHASE1":81,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":93,"NA":95},{"trials":82,"activeCount":58},[],{"trials":84,"activeCount":58},[],{"trials":86,"activeCount":58},[],{"trials":88,"activeCount":9,"soonestReadout":39},[89],{"nctId":37,"briefTitle":38,"status":66,"phases":90,"primaryCompletion":39,"completion":68,"start":69,"enrollment":70,"conditions":91,"interventions":92},[50],[72],[40,74],{"trials":94,"activeCount":58},[],{"trials":96,"activeCount":58},[],{"intervention":45,"totalTrials":9,"cells":98},{"EARLY_PHASE1":99,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":120},{"trials":100,"activeCount":9,"soonestReadout":44},[101],{"nctId":42,"briefTitle":43,"status":102,"phases":103,"primaryCompletion":44,"completion":104,"start":105,"enrollment":106,"conditions":107,"interventions":111},"ACTIVE_NOT_RECRUITING",[47],"2025-12-30","2021-09-24",80,[108,109,110],"Neonatal Disease","Parenting","Premature Birth",[45],{"trials":113,"activeCount":58},[],{"trials":115,"activeCount":58},[],{"trials":117,"activeCount":58},[],{"trials":119,"activeCount":58},[],{"trials":121,"activeCount":58},[],{"intervention":123,"totalTrials":9,"cells":124},"Initiation of vasopressine as a first vasoconstrictive drug",{"EARLY_PHASE1":125,"PHASE1":127,"PHASE2":129,"PHASE3":131,"PHASE4":133,"NA":148},{"trials":126,"activeCount":58},[],{"trials":128,"activeCount":58},[],{"trials":130,"activeCount":58},[],{"trials":132,"activeCount":58},[],{"trials":134,"activeCount":58},[135],{"nctId":136,"briefTitle":137,"status":138,"phases":139,"primaryCompletion":140,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":146},"NCT06265259","Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients","UNKNOWN",[51],"2025-12-31","2026-01-31","2023-12-15",145,[145],"Circulatory Shock",[123,147],"Initiation of noradrenaline as a first vasoconstrictive drug",{"trials":149,"activeCount":58},[],{"intervention":147,"totalTrials":9,"cells":151},{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":158,"PHASE4":160,"NA":166},{"trials":153,"activeCount":58},[],{"trials":155,"activeCount":58},[],{"trials":157,"activeCount":58},[],{"trials":159,"activeCount":58},[],{"trials":161,"activeCount":58},[162],{"nctId":136,"briefTitle":137,"status":138,"phases":163,"primaryCompletion":140,"completion":141,"start":142,"enrollment":143,"conditions":164,"interventions":165},[51],[145],[123,147],{"trials":167,"activeCount":58},[],{"intervention":169,"totalTrials":9,"cells":170},"Tapentadol",{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":175,"PHASE3":177,"PHASE4":179,"NA":194},{"trials":172,"activeCount":58},[],{"trials":174,"activeCount":58},[],{"trials":176,"activeCount":58},[],{"trials":178,"activeCount":58},[],{"trials":180,"activeCount":58},[181],{"nctId":182,"briefTitle":183,"status":138,"phases":184,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":192},"NCT06269770","Tapentadol vs Tramadol in Total Knee Arthroplasty",[51],"2025-05-01","2025-06-01","2023-05-01",96,[190,191,31],"Total Knee Replacement","Post-operative Pain",[169,193],"Tramadol",{"trials":195,"activeCount":58},[],{"intervention":193,"totalTrials":9,"cells":197},{"EARLY_PHASE1":198,"PHASE1":200,"PHASE2":202,"PHASE3":204,"PHASE4":206,"NA":212},{"trials":199,"activeCount":58},[],{"trials":201,"activeCount":58},[],{"trials":203,"activeCount":58},[],{"trials":205,"activeCount":58},[],{"trials":207,"activeCount":58},[208],{"nctId":182,"briefTitle":183,"status":138,"phases":209,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":210,"interventions":211},[51],[190,191,31],[169,193],{"trials":213,"activeCount":58},[],{"intervention":215,"totalTrials":9,"cells":216},"Pravastatin",{"EARLY_PHASE1":217,"PHASE1":230,"PHASE2":232,"PHASE3":234,"PHASE4":236,"NA":238},{"trials":218,"activeCount":58},[219],{"nctId":220,"briefTitle":221,"status":222,"phases":223,"primaryCompletion":224,"completion":224,"start":225,"enrollment":226,"conditions":227,"interventions":229},"NCT00702130","Pravastatin and Ventilatory Associated Pneumonia","COMPLETED",[47],"2010-04","2008-06",152,[228],"Ventilator Associated Pneumonia",[215],{"trials":231,"activeCount":58},[],{"trials":233,"activeCount":58},[],{"trials":235,"activeCount":58},[],{"trials":237,"activeCount":58},[],{"trials":239,"activeCount":58},[],{"intervention":241,"totalTrials":9,"cells":242},"N-acetyl cystein",{"EARLY_PHASE1":243,"PHASE1":256,"PHASE2":258,"PHASE3":260,"PHASE4":262,"NA":264},{"trials":244,"activeCount":58},[245],{"nctId":246,"briefTitle":247,"status":138,"phases":248,"primaryCompletion":249,"completion":250,"start":251,"enrollment":252,"conditions":253,"interventions":255},"NCT02937376","Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise",[47],"2023-06-01","2023-11-01","2023-02-01",12,[254],"G6PD Deficiency",[241],{"trials":257,"activeCount":58},[],{"trials":259,"activeCount":58},[],{"trials":261,"activeCount":58},[],{"trials":263,"activeCount":58},[],{"trials":265,"activeCount":58},[],{"intervention":267,"totalTrials":9,"cells":268},"N-acetylcysteine and ascorbic acid",{"EARLY_PHASE1":269,"PHASE1":282,"PHASE2":284,"PHASE3":286,"PHASE4":288,"NA":290},{"trials":270,"activeCount":58},[271],{"nctId":272,"briefTitle":273,"status":138,"phases":274,"primaryCompletion":275,"completion":276,"start":277,"enrollment":278,"conditions":279,"interventions":281},"NCT01017796","Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients",[47],"2010-01","2010-06","2009-01",100,[280],"Contrast Induced Nephropathy",[267],{"trials":283,"activeCount":58},[],{"trials":285,"activeCount":58},[],{"trials":287,"activeCount":58},[],{"trials":289,"activeCount":58},[],{"trials":291,"activeCount":58},[],{"intervention":293,"totalTrials":294,"cells":295},"Colistin",2,{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":302,"PHASE4":304,"NA":306},{"trials":297,"activeCount":58},[],{"trials":299,"activeCount":58},[],{"trials":301,"activeCount":58},[],{"trials":303,"activeCount":58},[],{"trials":305,"activeCount":58},[],{"trials":307,"activeCount":58},[308,319],{"nctId":309,"briefTitle":310,"status":138,"phases":311,"primaryCompletion":312,"completion":313,"start":314,"enrollment":226,"conditions":315,"interventions":318},"NCT04208945","Nebulized Colistin for Gram Negative VAP Prevention.",[52],"2021-04","2021-09","2019-12",[316,317],"Pneumonia, Ventilator-associated","Gram-Negative Pneumonia",[293],{"nctId":320,"briefTitle":321,"status":222,"phases":322,"primaryCompletion":323,"completion":323,"start":324,"enrollment":325,"conditions":326,"interventions":329},"NCT01025921","Tracheobronchitis Prevention Trial",[52],"2013-05","2009-11",84,[327,328],"Tracheobronchitis","Pneumonia",[330],"colistin",{"intervention":332,"totalTrials":294,"cells":333},"Dexmedetomidine",{"EARLY_PHASE1":334,"PHASE1":336,"PHASE2":338,"PHASE3":340,"PHASE4":342,"NA":344},{"trials":335,"activeCount":58},[],{"trials":337,"activeCount":58},[],{"trials":339,"activeCount":58},[],{"trials":341,"activeCount":58},[],{"trials":343,"activeCount":58},[],{"trials":345,"activeCount":58},[346,358],{"nctId":347,"briefTitle":348,"status":138,"phases":349,"primaryCompletion":350,"completion":351,"start":352,"enrollment":353,"conditions":354,"interventions":356},"NCT04105946","Opioid Free Anesthesia in ENT Surgery",[52],"2023-10","2023-12","2022-10",200,[355],"Functional Endoscopic Sinus Surgery",[332,357],"Remifentanil",{"nctId":359,"briefTitle":360,"status":138,"phases":361,"primaryCompletion":362,"completion":363,"start":364,"enrollment":353,"conditions":365,"interventions":368},"NCT04766047","The Effect of Dexmedetomidine on Kidney Function in EVAR",[52],"2023-11-30","2024-02-01","2021-08-30",[366,332,367],"Acute Kidney Injury","Endovascular Aortic Repair",[332],{"intervention":370,"totalTrials":9,"cells":371},"Dimenhydrinate",{"EARLY_PHASE1":372,"PHASE1":374,"PHASE2":376,"PHASE3":378,"PHASE4":380,"NA":382},{"trials":373,"activeCount":58},[],{"trials":375,"activeCount":58},[],{"trials":377,"activeCount":58},[],{"trials":379,"activeCount":58},[],{"trials":381,"activeCount":58},[],{"trials":383,"activeCount":58},[384],{"nctId":385,"briefTitle":386,"status":222,"phases":387,"primaryCompletion":388,"completion":388,"start":389,"enrollment":390,"conditions":391,"interventions":393},"NCT05590936","Dimenydrinate vs Ondansetron for PONV (DONV)",[52],"2022-12-07","2018-01-01",190,[392],"PONV in Laparoscopic Cholocystectomies",[370,394],"Ondansetron iv",{"intervention":394,"totalTrials":9,"cells":396},{"EARLY_PHASE1":397,"PHASE1":399,"PHASE2":401,"PHASE3":403,"PHASE4":405,"NA":407},{"trials":398,"activeCount":58},[],{"trials":400,"activeCount":58},[],{"trials":402,"activeCount":58},[],{"trials":404,"activeCount":58},[],{"trials":406,"activeCount":58},[],{"trials":408,"activeCount":58},[409],{"nctId":385,"briefTitle":386,"status":222,"phases":410,"primaryCompletion":388,"completion":388,"start":389,"enrollment":390,"conditions":411,"interventions":412},[52],[392],[370,394],{"intervention":414,"totalTrials":9,"cells":415},"Carotid Stenosis",{"EARLY_PHASE1":416,"PHASE1":418,"PHASE2":420,"PHASE3":422,"PHASE4":424,"NA":426},{"trials":417,"activeCount":58},[],{"trials":419,"activeCount":58},[],{"trials":421,"activeCount":58},[],{"trials":423,"activeCount":58},[],{"trials":425,"activeCount":58},[],{"trials":427,"activeCount":58},[428],{"nctId":429,"briefTitle":430,"status":138,"phases":431,"primaryCompletion":432,"completion":433,"start":434,"enrollment":435,"conditions":436,"interventions":439},"NCT04821700","Atrial Fibrillation and Carotid Atherosclerosis in Ischemic Stroke Patients-(AFCAS)",[],"2021-03-25","2021-04-05","2020-03-20",3000,[437,438,414],"Ischemic Stroke","Atrial Fibrillation",[414],{"intervention":441,"totalTrials":9,"cells":442},"Natural Aloe Vera",{"EARLY_PHASE1":443,"PHASE1":445,"PHASE2":447,"PHASE3":449,"PHASE4":451,"NA":453},{"trials":444,"activeCount":58},[],{"trials":446,"activeCount":58},[],{"trials":448,"activeCount":58},[],{"trials":450,"activeCount":58},[],{"trials":452,"activeCount":58},[],{"trials":454,"activeCount":58},[455],{"nctId":456,"briefTitle":457,"status":222,"phases":458,"primaryCompletion":459,"completion":460,"start":461,"enrollment":462,"conditions":463,"interventions":466},"NCT03934762","Aloe Vera Ointment Application and Skeletal Muscle Recovery",[52],"2019-05-15","2019-05-30","2019-04-25",10,[21,464,465],"Exercise-induced Aseptic Inflammation","Performance",[441,467],"Aloe vera soup",{"intervention":467,"totalTrials":9,"cells":469},{"EARLY_PHASE1":470,"PHASE1":472,"PHASE2":474,"PHASE3":476,"PHASE4":478,"NA":480},{"trials":471,"activeCount":58},[],{"trials":473,"activeCount":58},[],{"trials":475,"activeCount":58},[],{"trials":477,"activeCount":58},[],{"trials":479,"activeCount":58},[],{"trials":481,"activeCount":58},[482],{"nctId":456,"briefTitle":457,"status":222,"phases":483,"primaryCompletion":459,"completion":460,"start":461,"enrollment":462,"conditions":484,"interventions":485},[52],[21,464,465],[441,467],{"intervention":487,"totalTrials":9,"cells":488},"Mepolizumab",{"EARLY_PHASE1":489,"PHASE1":491,"PHASE2":493,"PHASE3":495,"PHASE4":497,"NA":499},{"trials":490,"activeCount":58},[],{"trials":492,"activeCount":58},[],{"trials":494,"activeCount":58},[],{"trials":496,"activeCount":58},[],{"trials":498,"activeCount":58},[],{"trials":500,"activeCount":58},[501],{"nctId":502,"briefTitle":503,"status":222,"phases":504,"primaryCompletion":505,"completion":505,"start":506,"enrollment":507,"conditions":508,"interventions":510},"NCT05147155","Impulse Oscillometry Measurements in Severe Eosinophilic Asthmatics Before and After Anti-IL-5 Factor Initiation",[],"2023-10-23","2021-04-19",130,[509],"Severe Asthma",[487],{"intervention":512,"totalTrials":9,"cells":513},"Epidural analgesia",{"EARLY_PHASE1":514,"PHASE1":516,"PHASE2":518,"PHASE3":520,"PHASE4":522,"NA":524},{"trials":515,"activeCount":58},[],{"trials":517,"activeCount":58},[],{"trials":519,"activeCount":58},[],{"trials":521,"activeCount":58},[],{"trials":523,"activeCount":58},[],{"trials":525,"activeCount":58},[526],{"nctId":527,"briefTitle":528,"status":222,"phases":529,"primaryCompletion":530,"completion":531,"start":532,"enrollment":533,"conditions":534,"interventions":541},"NCT04108546","Massage and Electroacupuncture in Chronic Lumbar Pain",[52],"2024-10-01","2024-12-31","2020-02-01",110,[535,536,537,538,539,540],"Back Pain","Lumbar","Anesthesia, Local","Epidural","Electroacupuncture","Massage",[512],{"intervention":357,"totalTrials":9,"cells":543},{"EARLY_PHASE1":544,"PHASE1":546,"PHASE2":548,"PHASE3":550,"PHASE4":552,"NA":554},{"trials":545,"activeCount":58},[],{"trials":547,"activeCount":58},[],{"trials":549,"activeCount":58},[],{"trials":551,"activeCount":58},[],{"trials":553,"activeCount":58},[],{"trials":555,"activeCount":58},[556],{"nctId":347,"briefTitle":348,"status":138,"phases":557,"primaryCompletion":350,"completion":351,"start":352,"enrollment":353,"conditions":558,"interventions":559},[52],[355],[332,357],{"intervention":561,"totalTrials":9,"cells":562},"Drugs, Generic",{"EARLY_PHASE1":563,"PHASE1":565,"PHASE2":567,"PHASE3":569,"PHASE4":571,"NA":573},{"trials":564,"activeCount":58},[],{"trials":566,"activeCount":58},[],{"trials":568,"activeCount":58},[],{"trials":570,"activeCount":58},[],{"trials":572,"activeCount":58},[],{"trials":574,"activeCount":58},[575],{"nctId":576,"briefTitle":577,"status":138,"phases":578,"primaryCompletion":579,"completion":579,"start":580,"enrollment":581,"conditions":582,"interventions":585},"NCT03727412","Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA",[52],"2021-10-01","2018-08-01",186,[583,584],"Aneurysm Abdominal","Endovacular Repair",[561]]